High gluten intake during the first 5 years of life was a statistically significant, independent risk factor for both celiac disease (CD) autoimmunity and CD in genetically predisposed children.
An interdisciplinary group treatment for fecal incontinence in children (called “Poop group” by investigators) is a promising alternative for up to 60% of patients who fail to respond to standard care.
Researchers conducted a randomized controlled trial to assess tolerability and efficacy of a Crohn disease exclusion diet plus partial enteral nutrition compared with exclusive enteral nutrition.
The impact of eradicated Helicobacter pylori on the pediatric gastric microbial community structure shows restoration of bacterial diversity consistent with noninfected children in the same endemic region.
Researchers found approximately one-third of patients with type 1 diabetes and celiac disease were able to achieve sustained celiac-specific antibody negativity after celiac disease diagnosis.
Pediatric patients with suspected bowel and bladder dysfunction may not need specialty intervention if they receive appropriate treatment in primary care.
Among children under age 5 years with acute gastroenteritis, Lactobacillus reuteri DSM 17938 as an adjunct to rehydration therapy did not reduce the duration of diarrhea compared with placebo.
Children with nonspecific chronic cough may not need to be routinely evaluated or treated with empirical therapy for gastroesophageal reflux without overt regurgitation.
Researchers conducted a retrospective study of pediatric patients with inflammatory bowel disease to estimate the risk for cancer and mortality associated with this diagnosis.